Monday, April 28, 2025

 



Gamma Knife Radiosurgery for Neurofibromatosis-II

20 years male from Afghanistan, underwent excision of right CPA SOL in December 13, 2023  insertion of VP shunt in November 27, 2023 presented with complains headache for 6 months, difficulty in walking for 2 & ½ months & loss of right hearing for 1 & ½ months. Patient has no history of radiation & chemotherapy. On clinical examination patient is on wheel chair, right facial palsy, loss of right hearing & ataxia. MRI brain with contrast dated October 29, 2023 shows extra axial enhancing mass lesions seen in bilateral CPA with extension into intra canalicular component suggestive of neurofibromatosis-2. 


Follow up Comparative Study after 6months:

Patient visited the gamma knife center for first routine follow up presented with good resolved  clinical symptoms.Recent MRI brain with contrast dated June 29, 2024 shows significant regression in the targeted Right lesion and sizeable regression in left side when compared with previous MRI brain with contrast dated October 29, 2023 consistent with good ongoing control of lesion.



Tuesday, April 22, 2025

 


Gamma Knife Radiosurgery for Left Acoustic Schwannoma:

Case Summary:

42 years male, presented with complaints of headache, vertigo, imbalance & slightly decreased left hearing for 1 year. Patient has no history of surgery, chemotherapy and radiation therapy. On clinical examination, patient has slightly decreased left hearing & ataxia. MRI brain with contrast dated May 16, 2023 shows local lesion appearing heterogeneously hyper intense on T2 & flair images noted in left acoustic schwannoma. Audiometry attached. Risks of GKSRS have been explained. Written and valid consent obtained to proceed.



Follow up Comparative Study dated April 2025:

Patient visited the GKSRS center for the first follow up presented with recent MRI Brain with contrast shows significant reduction in targeted SOL  when compared with previous MRI Brain with contrast , consistent with ongoing good tumor control.




 Gamma Knife Radiosurgery For Astrocytoma WHO Grade-II:

Case Summary:

38 years of male, underwent craniotomy for excision of SOL in August 29, 2023 presented with the complaints of fits with loss of consciousness since August 2023 & weakness in left limbs after surgery. Patient has no history of radiation & chemotherapy. On clinical examination, patient has 4/5 power in left limbs. MRI brain with contrast dated September 10, 2023 shows abnormal signal intensity mass seen in right fronto-parietal lesion with post surgical changes. Histopathology dated September 11, 2023 shows Astrocytoma G-II. Risks of GKSRS have been explained. Written and valid consent obtained to proceed.



Follow up Comparative Study After 1 year (April 2025):
Patient consulted Gamma Knife radiosurgery center for first follow up , presented with recent MRI Brain with contrast shows almost complete resolution of targeted lesion when compared with previous MRI Brain with contrast,consistent with ongoing good response to GKSRS Therapy.






Saturday, April 19, 2025

 


Gamma Knife Radiosurgery For Right Acoustic Schwannoma.

Case Summary:

40 years lady , presented with complaints of loss of right hearing for 3 months, numbness in tongue & face for 3 months, headache & vertigo for few days. Patient has no history of radiation & chemotherapy. On clinical examination patient has decrease touch sensation in right side of face, loss of right hearing & ataxia. MRI brain with contrast dated December 20, 2023 shows extra axial enhancing abnormal signal intensity mass seen in right CPA with bulges into porus acusticus suggestive of schwannoma. Risks of GKSRS have been explained Written and valid consent obtained to proceed.



Follow up Comparative Study April 16,2025: AFTER ONE YEAR

Patient visited the gamma knife center for the first follow up presented with recent MRI brain dated April 10,2025 shows significant reduction in targeted lesion when compared with previous MRI brain with contrast dated July 06, 2024, consistent with ongoing good control of tumor.